• SENSEX 80,918.78
    -266.80 (--0.33%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Windlas Biotech Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 36133.0
  • ISIN : INE0H5O01029
966.05 -23 (-2.33%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    960.30

  • Today’s High

    999.90

  • Open

    999.90

  • Perv Close

    989.05

  • 52W Low

    665.10

  • 52W High

    1,198.25

Key Indicators

  • P/E(TTM)

    33.35

  • Mar.Cap (₹Cr.)

    2,019.07

  • Div & Yield %

    0.60

  • Book Value(₹)

    241.99

  • Debt-Equity Ratio

    -2.33

  • AGM Date

    01-Aug-2025

  • EPS

    29.01

  • P/E Ratio

    33.35

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    2,019.07

  • RONW (%)

    13.66

  • ROCE (%)

    18.07

Score Board

  • Equity (₹ in Cr.)

    10.45

  • BV (₹)

    242.00

  • Sales( ₹ in Cr.)

    759.88

  • NP (in Cr.)

    60.64

  • NP Var(%)

    4.0

  • Div%

    116.0

  • CPS (₹)

    42.40

  • EPS (₹)

    29.00

  • Traded Value (₹ in Lakhs)

    2,022.00

  • 52 Week High

    1,198.25

  • 52 Week Low

    665.10

  • Price BSE

    967.0

  • Price NSE

    966.00

  • Market Capital( in Cr.)

    2,022.00

  • P/C Ratio

    22.80

  • P/E Ratio

    33.30

  • Price Vs.BV

    29.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 759.88 630.96 513.08 465.93 427.60 328.85
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 759.88 630.96 513.08 465.93 427.60 328.85
Other Income 17.65 13.47 9.97 6.71 3.09 0.96
Stock Adjustments 21.52 -9.59 15.27 4.74 -3.67 12.75
Total Income 799.05 634.84 538.32 477.38 427.02 342.56
EXPENDITURE :            
Raw Materials 493.38 386.59 340.71 307.56 270.74 224.35
Power and Fuel Cost 21.61 16.15 12.90 11.01 11.53 8.04
Employee Cost 122.92 87.46 70.32 63.41 58.32 43.88
Other Manufacturing Expenses 11.57 10.52 8.63 8.95 8.37 4.28
Selling and Administration Expenses 33.53 35.92 30.13 23.08 15.09 15.68
Miscellaneous Expenses 4.28 6.63 5.41 3.78 37.54 4.70
Employee Benefit Expenses 122.92 87.46 70.32 63.41 58.32 43.88
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 687.29 543.27 468.10 417.78 401.60 300.93
Operating Profit 111.76 91.57 70.21 59.60 25.44 41.63
Interest 4.38 1.10 0.79 1.42 1.29 2.37
Gross Profit 107.38 90.47 69.42 58.18 24.15 39.26
Depreciation 27.99 13.44 12.36 12.15 12.97 8.69
Profit Before Tax 79.39 77.03 57.06 46.03 11.18 30.57
Current Tax 18.27 17.34 14.35 10.13 4.84 8.24
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.47 1.54 0.06 -2.66 1.33 -0.13
Reported Net Profit 60.65 58.14 42.64 38.56 5.01 22.46
Extraordinary Items 0.01 0.00 0.65 0.01 -14.49 0.00
Adjusted Net Profit 60.64 58.14 41.99 38.55 19.50 22.46
Adjustment below Net Profit -0.54 -0.24 -0.16 -0.18 -26.37 0.00
P & L Balance brought forward 226.29 176.70 141.84 103.46 124.82 98.49
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 11.50 8.32 7.63 0.00 0.00 0.00
P & L Balance carried down 274.90 226.29 176.70 141.84 103.46 120.95
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 116.00 110.00 80.00 70.00 0.00 0.00
Dividend Per Share(Rs) 5.80 5.50 4.00 3.50 0.00 0.00
Earnings Per Share-Unit Curr 28.94 27.96 20.38 17.69 7.81 35.03
Earnings Per Share(Adj)-Unit Curr 28.94 27.96 20.38 17.69 - -
Book Value 241.31 216.51 192.42 181.30 310.39 337.66
Book Value(Adj)-Unit Curr 241.31 216.51 192.42 181.30 - -

Shareholding Pattern

  • Promoter Group

    62.34%

  • Public Share Holding

    37.66%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,684,012 22.35 4,684,012 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 8,381,340 39.99 8,381,340 1
Sub Total 13,065,352 62.34 13,065,352 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 302,450 1.44 302,450 28
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,425,046 6.80 1,425,046 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 925,367 4.42 925,367 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,652,863 12.66 2,652,863 40
2] Non Institution
Bodies Corporate 395,464 1.89 395,464 170
Clearing Members 67 0.00 67 1
Directors of their Relatives 13,925 0.07 13,925 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 215,298 1.03 215,298 717
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 135,914 0.65 135,914 1,085
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 351,977 1.68 351,977 3
Individuals holding nominal share capital up to Rs. 1 lakh 4,022,088 19.19 4,022,088 43,840
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,597 0.01 2,597 2
Others 12,934 0.06 12,934 2
Sub Total 5,241,096 25.01 5,241,096 45,840
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 20,959,311 100.00 20,959,311 45,887

Company Background

Windlas Biotech LtdPharmaceuticals - Indian - Formulations

  • Windlas Biotech Ltd
  • BSE Code : 36133.0
  • ISIN : INE0H5O01029

  • Incorporation Year

    2001

  • Registered Office

    40/1 Mohabewala Industrial
    Area, Dehradun,
    Uttarakhand-248110

  • Telephone

    91-135-6608000

  • FAX

  • Chairman

    Vivek Dhariwal

  • Managing Director

    Hitesh Windlass

  • Company Secretary

    Ananta Narayan Panda

  • Auditor

    S S Kothari Mehta & Co LLP/J C Bhalla & Co

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Windlas Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Windlas Biotech 967.45 777.52 759.88 33.34 16.79
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10